INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2015
Net Assets |
£249m |
Net Assets per share |
612p |
Share price |
540p |
Total value of unquoted investments |
£19m |
Total number of portfolio companies |
92 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
8.0 |
Amgen |
7.0 |
Biogen |
6.8 |
Celgene |
6.7 |
Regeneron |
6.1 |
Mylan |
5.4 |
Alexion |
4.1 |
Vertex |
3.7 |
Biomarin |
2.9 |
Chimerix |
2.8 |
|
----------- |
Total |
53.5 |
Portfolio Profitability |
% NAV |
Profitable |
53 |
Turning Profitable 2015 |
6 |
Unprofitable |
41 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
87 |
Europe & UK |
13 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
92 |
Unquoted |
8 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
16 JULY 2015